IT has been proposed that iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (123I-BMIPP) is an agent for myocardial fatty acid metabolism in animal models. The aim of the present study was to determine whether alterations in fatty acid uptake and/or utilization in patients with hypertrophi
Serial change of iodine-123 metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy
โ Scribed by K. Yamakado; K. Takeda; T. Kitano; T. Nakagawa; Y. Futagami; T. Konishi; M. Hamada; T. Nakano; T. Ichihara
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 914 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
โฆ Synopsis
Serial change of the metaiodobenzylguanidine iodine-123 (123I-MIBG) myocardial concentration was investigated in patients with dilated cardiomyopathy (DCM). Eight DCM patients and 6 control subjects were examined. After the injection of thallium-201 and 123I-MIBG, planar chest images were obtained simultaneously for both tracers in every 30-60 rain over 5 h. Serial changes of myocardial uptake ratio (MUR) were compared for both tracers. In DCM, the initial MUR of 123I-MIBG did not differ significantly from that of the controls. The washout of 123I-MIBG from the myocardium, however, was significantly increased in DCM. In particular, the decrease in the early phase (1545 rain) was significantly larger in DCM than in the controls (21.2% _+7.5% vs. 5.3% + 4.0%, P < 0.01), showing a significant negative correlation with the left ventricular ejection fraction (r = -0.72 P < 0.05). For 2ยฐ1T1, neither the initial MUR nor the washout rate different significantly between the two. Thus, an early rapid decrease of the m3I-MIBG myocardial concentration might characterize DCM and reflect the severity of this disease.
๐ SIMILAR VOLUMES